BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3140070)

  • 21. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
    Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
    J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of different tumor markers in the early diagnosis and prognosis of pancreatic carcinoma and chronic pancreatitis.
    Hámori J; Arkosy P; Lenkey A; Sápy P
    Acta Chir Hung; 1997; 36(1-4):125-7. PubMed ID: 9408313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low serum testosterone/dihydrotestosterone ratio in patients with pancreatic carcinoma.
    Robles-Diaz G; Diaz-Sanchez V; Mendez JP; Altamirano A; Wolpert E
    Pancreas; 1987; 2(6):684-7. PubMed ID: 3438305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Int J Pancreatol; 1994 Jun; 15(3):171-7. PubMed ID: 7930777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early and late long-term effects of vasectomy on serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone levels.
    Mo ZN; Huang X; Zhang SC; Yang JR
    J Urol; 1995 Dec; 154(6):2065-9. PubMed ID: 7500459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone, luteinizing hormone and growth hormone in blood following surgical trauma.
    Carstensen H; Terner N; Thorén L; Wide L
    Acta Chir Scand; 1972; 138(1):1-5. PubMed ID: 5036394
    [No Abstract]   [Full Text] [Related]  

  • 27. Sexual and gonadal functions in elderly uremic patients on hemodialysis.
    Mastrogiacomo I; De Besi L; Serafini E; La Greca G; Gasparotto ML; Lorenzi S; Zucchetta P
    J Endocrinol Invest; 1985; 8 Suppl 2():117-21. PubMed ID: 3928737
    [No Abstract]   [Full Text] [Related]  

  • 28. [Differential diagnostic evaluation of chronic pancreatitis in relation to pancreatic cancer based on clinical, laboratory chemical and diagnostic parameters. Studies of 174 patients in 10 years].
    Gronen G; Dombrowski H; Adler G; Lorenz-Meyer H
    Z Gastroenterol; 1986 Aug; 24(8):416-25. PubMed ID: 3532595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do male sex hormones protect from irritable bowel syndrome?
    Houghton LA; Jackson NA; Whorwell PJ; Morris J
    Am J Gastroenterol; 2000 Sep; 95(9):2296-300. PubMed ID: 11007231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FSH, LH and testosterone blood level in patients with psychogenic impotence.
    Legros JJ; Franchimont P; Palem-Vliers M; Servais J
    Endocrinol Exp; 1973; 7(1):59-64. PubMed ID: 4541063
    [No Abstract]   [Full Text] [Related]  

  • 31. [Considerations on the difficulty of early differential diagnosis of pancreatic carcinoma and chronic pancreatitis].
    Comes P; Giuffra F; Odicino M; Zanetti PP
    Minerva Dietol Gastroenterol; 1984; 30(2):107-9. PubMed ID: 6472690
    [No Abstract]   [Full Text] [Related]  

  • 32. [FSH, LH, estradiol and testosterone studies of the blood serum in endometriosis externa].
    Gunev V; Maleeva A; Spasov S; Melamed V; Trepechov S
    Akush Ginekol (Sofiia); 1981; 20(4):312-5. PubMed ID: 6795952
    [No Abstract]   [Full Text] [Related]  

  • 33. The basal levels of serum prolactin (PRL), luteinizine hormone (LH), follicle stimulating hormone (FSH), testosterone, thyroxine (T4), and cortisol in patients with pituitary mass: detection and evaluation.
    Namking M; Pavasuthipaisit K; Lerthamtewe W; Bunyaratavej S; Himathongkam T
    J Med Assoc Thai; 1981 Feb; 64(2):76-85. PubMed ID: 6785372
    [No Abstract]   [Full Text] [Related]  

  • 34. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
    Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in hormone levels after adjuvant chemoradiation in male rectal cancer patients.
    Yoon FH; Perera F; Fisher B; Stitt L
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1186-90. PubMed ID: 19095371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lowering prolactin level in a hyperprolactinemic man: responses of luteinizing hormone, follicle-stimulating hormone, and testosterone.
    Davis JL
    Arch Intern Med; 1982 Jan; 142(1):146-8. PubMed ID: 6797361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low free testosterone is an independent risk factor for Alzheimer's disease.
    Hogervorst E; Bandelow S; Combrinck M; Smith AD
    Exp Gerontol; 2004; 39(11-12):1633-9. PubMed ID: 15582279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-grade prostate cancer is associated with low serum testosterone levels.
    Schatzl G; Madersbacher S; Thurridl T; Waldmüller J; Kramer G; Haitel A; Marberger M
    Prostate; 2001 Apr; 47(1):52-8. PubMed ID: 11304729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differential diagnosis of chronic pancreatitis and cancer of the pancreas].
    Malinovskiĭ NN; Sokolov VI; Vasil'ev RKh
    Sov Med; 1971 May; 34(5):82-7. PubMed ID: 5159395
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro secretion of follicle-stimulating hormone by pituitary chromophobe adenomas.
    Takeuchi J; Handa H; Suda K; Aso T
    Surg Neurol; 1980 Oct; 14(4):303-9. PubMed ID: 6776644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.